LSBio
Polyclonal Rabbit anti-Human WNT5A Antibody (aa190-230, IHC, WB)

Western blot of human Wnt5A in human heart lysate in the 1) absence, 2) presence of immunizing peptide, 3) mouse and 4) rat heart using antibody at0.5 ug/ml.

Polyclonal Rabbit anti-Human WNT5A Antibody (aa190-230, IHC, WB)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Bovine, Human, Mouse, Non-Human Primate, Rat
Format:Liquid
See all Human WNT5A antibodies →
$394.00each
Catalog Number: LS-C47384-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
WNT5A antibody LS-C47384 is an unconjugated rabbit polyclonal antibody to WNT5A (aa190-230) from human. It is reactive with human, mouse, rat and other species. Validated for IHC and WB. Cited in 1 publication.
Application
IHC, IHC-P, WB
Reactivity
Bov, Hu, Ms, NHP, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
HWNT5A | Protein Wnt-5a | WNT-5A protein | WNT5A
Recommended Dilution: IHC-P
5 - 10 µg/ml
Recommended Dilution: WB
0.5 - 2 µg/ml
UniProt Number
P41221
SwissProt
P41221

Target

Target
Human WNT5A
Antigen Species
Human
Epitope
A portion of amino acids 190-230 of human Wnt5A.
Gene Name
WNT5A

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
A synthetic peptide corresponding to amino acids 190-230 NP_003383.2
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 8.5, 0.05% sodium azide
Concentration
1 mg/mL
Preservative
Yes
Purification Method
Protein G Affinity

Storage & Handling

Storage Conditions
Short term: 4°C Long term: Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition. Kazuki Wakizaka, Toshiya Kamiyama, Kenji Wakayama, Tatsuya Orimo, Shingo Shimada, Akihisa Nagatsu, Hirofumi Kamachi, Hideki Yokoo, Moto Fukai, Nozomi Kobayashi, Tomoko Mitsuhashi, Akinobu Taketomi. Oncology letters. 2020 November;20:268. PubMed: 32989402 PMC: PMC7517569

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.